Cargando…
Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients
Critically ill patients infected with SARS-CoV-2 display adaptive immunity, but it is unknown if they develop cross-reactivity to variants of concern (VOCs). We profiled cross-immunity against SARS-CoV-2 VOCs in naturally infected, non-vaccinated, critically ill COVID-19 patients. Wave-1 patients (w...
Autores principales: | Fraser, Douglas D., Patel, Maitray A., Van Nynatten, Logan R., Martin, Claudio, Seney, Shannon L., Miller, Michael R., Daley, Mark, Slessarev, Marat, Cepinskas, Gediminas, Juneja, Ganeem K., Sabourin, Vanessa, Fox-Robichaud, Alison, Yeh, Calvin H., Kim, Paul Y., Badrnya, Sigrun, Oehler, Susanne, Miholits, Markus, Webb, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797417/ https://www.ncbi.nlm.nih.gov/pubmed/36594041 http://dx.doi.org/10.1016/j.heliyon.2022.e12704 |
Ejemplares similares
-
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism
por: Patel, Maitray A., et al.
Publicado: (2022) -
A novel multiplex biomarker panel for profiling human acute and chronic kidney disease
por: Van Nynatten, Logan R., et al.
Publicado: (2023) -
Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022) -
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021) -
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
por: Patel, Maitray A., et al.
Publicado: (2023)